Hyperoxia During Cardiopulmonary Bypass in Adult Cardiac Surgery: A Randomized Controlled Pilot Study
| Registry | NCT07510672, acronym IPEROXIA |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, supportive care |
| Enrollment | 104 (Actual) |
| Sponsor | University of Padova (Other) |
| Conditions | AKI, Renal Replacement Therapy, NGAL, Arrythmia, Mechanical Ventilation, Tracheostomy, Mechanical Circulatory Support, ICU Length of Stay, Hospital Length of Stay, Mortality, Surgical Complication, Cardiac Surgery |
| Interventions | Hyperoxia group, Normoxia group (control) (Other) |
| Dates | start 2025-07-01, primary completion 2025-09-15, completion 2025-10-15, first posted 2026-04-03, last updated 2026-04-03 |
| Locations | 1 site in Italy |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for AKI All trials for Renal Replacement Therapy All trials of Hyperoxia group All trials of Normoxia group (control)
This single-center randomized controlled pilot trial evaluates the effects of intraoperative hyperoxia compared with normoxia during cardiopulmonary bypass (CPB) in adult patients undergoing elective cardiac surgery. The primary aim is to assess the impact on postoperative renal function. Secondary outcomes include inflammatory markers, cardiovascular and pulmonary complications, resource utilization, and short-term mortality.
This monocentric randomized controlled pilot trial enrolled adult patients undergoing elective cardiac surgery requiring CPB. Participants were randomized (1:1) to receive either normoxic (PaO₂ 70-150 mmHg) or hyperoxic (PaO₂ >300 mmHg) oxygenation strategies intraoperatively.
The study evaluates postoperative renal function using eGFR, NGAL, renal replacement therapy, and KDIGO classification. Secondary outcomes include IL-6 levels, arrhythmias, mechanical circulatory support, surgical complications, ventilation duration, ICU/hospital stay, and 28-day mortality.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Normoxia group | Sham comparator | Other: Normoxia group (control) | Normoxia group (control): After endotracheal intubation, FiO₂ was initially set to 0.3 and subsequently adjusted to maintain PaO₂ between 70 and 150 mmHg. During CPB, air and oxygen flows through the oxygenator were titrated to maintain a target PaO₂ between 70 and 150 mmHg. |
| Hyperoxia group | Experimental | Other: Hyperoxia group | Hyperoxia group (intervention): After endotracheal intubation, FiO₂ was maintained at 0.8 and subsequently adjusted to achieve PaO₂ above 300 mmHg. During CPB, air and oxygen flows through the oxygenator were titrated to maintain a target PaO₂ greater than 300 mmHg. |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * adult patients (>18 years old) * need for elective cardiac surgery requiring CPB (i.e., isolated valve repair/replacement, coronary artery bypass grafting, or ascending aorta surgery) * Time frame from July 1st to September 15th 2025 Exclusion Criteria: * refusal of consent, * pregnancy, * previous Intensive Care Unit (ICU) admission, * history of cardiac surgery requiring CPB, * signs of preoperative cardiogenic shock (defined as requiring inotropic support, intra-aortic balloon pump, or other mechanical circulatory assistance), * intraoperative need for circulatory arrest.
| Facility | City | Country | Status |
|---|---|---|---|
| Padova University Hospital | Padova, PD | Italy |